Frank Narcisi, DPM
Podiatrist · Chicago Heights, ILNPI 1619983061
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (55.8%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Medwest Associates accounts for 63.9% of it on its own, with 13 other manufacturers making up the rest. Reporting peaked in 2019 at $4,438 and has fallen 89.7% since, to $457 in 2025. Among podiatrist clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $197.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medwest Associates$5K
- Stryker$1K
- Kerecis Limited$431
- Arthrex$318
- KCI USA, Inc.$125
- Vertex$98
- plus $217 from 8 others
What the payments were for
- Travel & lodging$1,49021%
- Food & beverage$1,66323%
- Education$3,97556%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medwest Associates | 7 | $4,552 |
| Stryker(2 entities) | 10 | $1,388 |
| Kerecis Limited | 2 | $431 |
| Arthrex | 3 | $318 |
| KCI USA, Inc. | 1 | $125 |
| Vertex | 5 | $98 |
| Acera Surgical, Inc. | 1 | $62 |
| Johnson & Johnson | 1 | $47 |
| Cerapedics Inc. | 1 | $22 |
| Si-bone, Inc. | 1 | $20 |
| Ferring Pharmaceuticals Inc. | 1 | $19 |
| Orthofix Medical, Inc. | 1 | $17 |
| Pacira Pharmaceuticals Incorporated | 1 | $16 |
| TEI Medical Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SALVATION$702
- Kerecis Omega3 Wound$431
- HOFFMANN$430
- Kerecis Omega3 Surgibind$201
- Kerecis Omega3 GraftGuide$201
- Kerecis Omega3 SurgiClose$201
- T2$161
- FIXOS$161
- AXSOS$161
- ORTHOLOC 2 LAPIFUSE$160
- VAC VERAFLO CLEANSE CHOICE$125
- VAC VERAFLO$125
How this compares
$7,128 in reported general payments places this provider in the 90th percentile of 409 podiatrist providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium ErDiclofenac Sodium | 21 | $447 |
| Doxycycline Hyclate | 34 | $407 |
| Ketoconazole | 17 | $354 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $268 |
| Silver Sulfadiazine | 38 | $251 |
| Clindamycin Hcl | 16 | $180 |
| Methylprednisolone | 14 | $107 |
| SsdSilver Sulfadiazine | 18 | $93 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 14 | $84 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in Chicago Heights
- David YeagerMorrison$345K
- Paul KirchnerNew Lenox$143K
- William BushRockford$141K
- Daniel BrownHarrisburg$136K
- Syed HusainArlington Heights$82K
- Timothy GrahamTaylorville$70K
- Paul PotachWheeling$45K
- Steven JasonowiczBarrington$34K
- Jaclyn SchumannJoliet$29K
- Zehra HyderiAlgonquin$27K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.